Common Vulval Dermatosis

Future treatment options for dermatoses with vulvar involvement
Dr. med. Christine Brägelmann
MD - Board-certified Dermatologist

Lichen sclerosus - Clinical characteristics, course of disease and topical treatment
Pia Halonen
ob/gyn,
MD/PhD Helsinki University Hospital
University of Helsinki, Finland

Lunch Symposium in collaboration with Lumenis
Anna Jaeger
University Clinic Hamburg – Eppendorf
Dysplasia Center Hamburg at the
Jerusalem Hospital

Lichen planus – clinical characteristics, course of the disease and topical treatment
Dr Fiona Lewis
St John’s Institute of Dermatology,
Guy’s & St Thomas NHS Trust, London UK

Lichen planus - Lichen sclerosus | A (dermato) pathologist‘s view
Sigrid Regauer
Diagnostic- and Research Institute of Pathology
Medical University of Graz

Laser therapy of Lichen sclerosus: a randomized trial
C Tempfer
Univ.-Klinik f. Frauenheilkunde
Ruhr-Universität Bochum

Clinical information relevant for thepathologist, histologic characteristics of vulvar and vestibular tissue
James Scurry
MD
Anatomical Pathologist,
New South Wales Health Pathology,
Newcastle, Australia

 

FGM 

ANATOMY OF THE CLITORIS, TYPES (IN ADULTS AND MINORS) OF FGM/C, COMPLICATIONS AND MANAGEMENT (splitted in two parts because of file size: Download File Part 1 | Part 2)
Prof. Jasmine Abdulcadir
Staff physician. Responsible of the Ob Gyn Emergency Unit
FGM/C Outpatient clinic, HUG
Vulva clinic
Department of pediatrics, obstetrics and gynecology, Université de Gèneve

 

Infectious Disease + Hidradenitis 

Hidradenitis suppurativa
Mareike Alter
Klinik für Dermatologie
Leitung HTCM
Johannes-Wesling-Klinikum Minden
Universitätsklinik der Ruhr-Universität Bochum

Update STDs
Johan CHANAL
MD, MSc
Sexual Health Centre, Hôpital Hôtel-Dieu Paris
Syphilis referral centre, Paris
FRANCE

Candidosis & Aerobic Vaginitis: Diagnostic and Therapeutic Challenges
Švitrigailė Grincevičienė
Vilnius University

Indication and performance of molecular tests for suspected vulvovaginal infections
Prof. Dr. med. Werner Mendling
German Center for Infections
In Gynecology and Obstetrics
Wuppertal

 

Invasive Disease part 1

Prognostic impact and spatial interplay of immune cells in vulvar carcinomas
Dr. Niclas C. Blessin
University Medical Center Schleswig-Holstein

Vulvar Cancer: Epidemiology & Risk Factors
Christian Dannecker
ECSVD 2025

Vulvar Cancer - Surgery of the primary tumor
Sven Mahner
LMU Klinikum
Munich, Germany

 

Invasive Disease part 2

Vulvar cancer: Radiooncology incl. management of side effects
Prof. Dr. Cordula Petersen
UKE Hamburg
Dpt. Radiation Oncology
Medical Center

Vulvar Cancer - Treatment of the Lymphatics
Maaike Oonk
ECSVD 2025

Systemic therapy gynecologic squamous cell cancers – developments
Linn Wölber
Universitätsklinikum HH-Eppendorf
Dysplasiezentrum Hamburg am KHJ

 

Pre-Invasive Disease

ANAL LESIONS: screening, diagnosis and treatment
Andreia Albuquerque, MD PhD
Consultant Gastroenterologist
Associate Professor
Porto, Portugal

Prognostic biomarkers in VIN
Maaike Bleeker
pathologist
Amsterdam UMC, The Netherlands

Management / Treatment options for VIN
Niccolò Gallio, MD
University of Torino, Torino, Italy

M. Paget of the vulva
Prof. Dr. Monika Hampl
Leiterin der Dysplasie Einheit St. Elisabeth Krankenhaus
Köln Hohenlind und Mitarbeiteri des Dysplasiezentrum
Universitäts-Frauenklinik Düsseldorf

Prophylaxis of vulvar precancerous conditions, vaccination
Elmar A. Joura
Medical University Vienna
Department of Gynecologic Oncology
Comprehensive Cancer Center

VIN – Subtypes and Prognosis
Mario Preti
Department of Surgical Sciences
University of Torino, Italy

 

Vaginal Mircobiome

The Role of Pre-, Pro- and Postbiotics: Hype or hot stuff?
Anna Jaeger, MD
University Clinic Hamburg – Eppendorf
Dysplasia Center Hamburg at the
Jerusalem Hospital

THE NORMAL VAGINAL MICROBIOME
Hans Verstraelen
Ghent University
UZ Gent

WET MOUNT MICROSCOPY
Hans Verstraelen
Païvi Tommola
Pedro Vieira Baptista
Ghent University
UZ Gent

Dysbioses of the vaginal microbiome
Pedro Vieira-Baptista
Hospital Lusíadas Porto, Porto, Portugal
Department of Gynecology-Obstetrics and Pediatrics, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
Faculty of Medicine and Health Sciences, Ghent University, Ghent Belgium

 

Vulvar Pain

SVD Address: How Can We Move Forward with Vulvar Diseases? | ISSVD Address to ECSVD
Debbie Roepe
Executive Director, ISSVD

How do we move forward in improving treatment of women with PVD?
Ulrika Heddini
MD, PhD, Danderyds Hospital, Stockholm, Sweden

Provoked vulvodynia -up to date treatment
C. Damsted Petersen 
MD, Ph.D., Copenhagen, Denmark

 

Template

Powerpoint / PPTX template for the ECSVD 2025